Ossianix

Recent Finacing

Convertible

Recent Raise

Undisclosed

Ossianix develops CNS-targeted biopharmaceuticals using a proprietary shark vNAR single-domain antibody platform, engineering differentiated therapeutic formats for nervous system disorders.